Dr Reddys Laboratories (RDY) Income from Continuing Operations (2009 - 2023)

Dr Reddys Laboratories (RDY) has reported Income from Continuing Operations for 15 consecutive years, with 170000000.0 the latest figure, recorded in Q2 2023.

• Quarterly Income from Continuing Operations changed N/A year-over-year to 170000000.0 in Q2 2023, while the trailing twelve-month figure through Jun 2023 was 459000152.0 (changed N/A YoY) and the FY2026 annual result came in at 452000000.0, down 32.64% from the prior year.
• Income from Continuing Operations eased to 170000000.0 in Q2 2023 per RDY's latest filing, from 172000000.0 in the prior quarter.
• Over the last five years, Income from Continuing Operations for RDY reached as high as 172000000.0 in Q1 2023 and fell as low as 108000000.0 in Q3 2020.
• A 5-year average of 90250012.67 and a median of 110500000.0 in 2019 frame the typical range for Income from Continuing Operations.
• Annual changes were most pronounced in 2019 — Income from Continuing Operations jumped 131.82% — and 2020, when it sank 258.82%.
• Year by year, Income from Continuing Operations stood at 68000000.0 in 2019, then plunged by 258.82% to 108000000.0 in 2020, then surged by 224.07% to 134000000.0 in 2021, then fell by 12.69% to 117000000.0 in 2022, then surged by 45.3% to 170000000.0 in 2023.
• According to Business Quant data, Income from Continuing Operations over the past three periods registered 170000000.0, 172000000.0, and 117000000.0 for Q2 2023, Q1 2023, and Q4 2022 respectively.